Optimum Medical Therapy Can Positively Influence Long-Term Survival After EVAR

Main Category: Cardiovascular / Cardiology
Article Date: 24 Nov 2008 - 7:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

While most operators focus on anatomic and device related issues that may affect initial and long-term outcome, as in many types of vascular disease, other factors may be of equal importance in long-term survival of patients with aneurysms.

Barry T. Katzen, M.D. Professor of Radiology at the University of South Florida College of Medicine and Founder and Medical Director of the Baptist Cardiac and Vascular Institute in Miami, Florida, detailed analysis of over 10 years data performed at Institute has shown several negative predictors for long-term survival that are unrelated to the aneurysm itself.

This includes the effect of hemoglobin, as well as the effect on renal function on long-term survival. Interestingly, the presence of statin therapy seems to have improved long-term survival.

Dr. Katzen stated that in vascular therapy, one should not forget the importance of optimum medical therapy to improve overall outcome.

VEITH SYMPOSIUM - New York, November 19th to 23rd

Now in its fourth decade, VEITH SYMPOSIUM provides vascular surgeons, interventional radiologists, interventional cardiologists and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The 5-day event features rapid-fire presentations from world renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies and new techniques.

VEITHsymposium is sponsored by Cleveland Clinic, Cleveland, OH.

www.veithsymposium.org

Source
Pauline T. Mayer
www.ptmhcm.com